Transplantation Fails to Improve Survival in Mantle Cell Lymphoma

(MedPage Today) -- SAN DIEGO -- Patients with mantle cell lymphoma (MCL) and undetectable minimal residual disease (uMRD) after induction therapy did not live longer if they underwent hematopoietic cell transplantation (HCT), a randomized trial...